2
Longitudinal Program* offers 30% off the second Foundation Medicine Tests for patient which appropriate to like to explore the resistance mechanism after disease progression
*all account, except ramathibodi hospital
CGP informs acquired resistance mechanisms after TKI
treatment to support decision for subsequent line of treatment.2
Broad & Flexible portfolio of tissue- and liquid-based
CGP cover both in-house and send-out NGS.7
As the same gene list is present in both tissue and liquid panels, they can be used for reflect testing to identify tumor heterogeneity and for liquid biopsy tests when tissue is not practical, giving patients more options.
